tumefactive MS
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/0/3/2/9/4/303d2d5e71d6ef83760b3aa256a9d1_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/1/3/9/7/2/7709bdc89bc35328b6d80f512606dc_big_gallery_thumb.jpg)
Tumefactive multiple sclerosis is a term used to describe patients with established multiple sclerosis who develop large aggressive demyelinating lesions, similar/identical in appearance to those seen in sporadic tumefactive demyelinating lesions (TDL). TDL is now considered to be a separate entity, lying on a spectrum between multiple sclerosis and postinfectious demyelination/acute disseminated encephalomyelitis (ADEM) .
This appears at first to be an unnecessarily complicated and pedantic distinction, however, this is potentially important as patients who present with a tumefactive demyelinating lesion do not usually progress to multiple sclerosis . Additionally, there may be histopathological differences between a TDL and tumefactive multiple sclerosis plaques, namely the presence of more pronounced axonal damage in the latter .
When reading about demyelination, one must be wary of older publications that do not draw a distinction between multiple sclerosis with larger tumefactive-like lesions and what is now considered true tumefactive demyelinating lesions.
Siehe auch:
- Hirnabszess
- Encephalomyelitis disseminata
- ZNS Lymphom
- tumefaktive Demyelinisierung
- inkomplettes Ringenhancement
- acute malignant Marburg type
und weiter:
![Click für weniger anzeigen](/sites/all/modules/pacs/tools/imgs/collapse_up.png)
![](/sites/all/modules/pacs/tools/imgs/Iris_color_40.png)